Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01056042Phase 4Completed
Phase 4, randomised, open-label trial of medroxyprogesterone acetate in endometriosis (2 arms), sponsored by Prince of Songkla University. Primary endpoint: Patients' satisfaction with the treatment at 1.5 years. Started Jun 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01056042.